QUESTO HUB
QUESTO HEALTHCARE ECOSYSTEM
Clinical Pharmacology & Maternal-Fetal Drug Safety Center
Topical Erythromycin
Prescribing & Clinical Reference: Compiled from official regulatory labeling (US FDA PLLR, NIH LactMed®, EMA). Clinical decisions during pregnancy and lactation require individualized patient assessment and physician consultation.
1. Pregnancy Evidence & Regulatory Labeling
FDA Pregnancy and Lactation Labeling Rule (PLLR 8.1) & EMA SmPC Section 4.6
Clinical Risk Summary
European regulatory assessment under EMA SmPC Section 4.6 (Fertility, pregnancy and lactation).
2. Lactation & Breastfeeding Safety
NIH / NLM LactMed® Database & FDA Labeling Section 8.2
Summary of Use during Lactation
Review infant exposure and nursing considerations before administration.
Drug Levels in Breast Milk & Relative Infant Dose
Relative Infant Dose (RID)
Indexed in Clinical Studies
RID <10% is generally considered low by clinical guidelines.
Milk Concentration & Transport
Evaluated in human/animal pharmacokinetic models.
4. Regulatory Source Provenance & Comparison
Direct attribution to official regulatory documents without synthesized consensus
| Regulatory Organization | Jurisdiction | Document / Framework | Effective Date | Official Source Link |
|---|---|---|---|---|
|
European Medicines Agency (EMA)
EMA Summary of Product Characteristics (SmPC 4.6)
|
European Union | regulatory_label | Recent | Official Record |
European Medicines Agency (EMA)
EMA Summary of Product Characteristics (SmPC 4.6)
European Union
Framework:
regulatory_label
Effective Date:
Recent